Last news
BILIGHT Concludes Japan PV EXPO 2026: Leading the "Powering AI" Era with Full-Scenario Perovskite Solutions

BILIGHT Concludes Japan PV EXPO 2026: Leading the "Powering AI" Era with Full-Scenario Perovskite Solutions

TOKYO, March 17, 2026 /PRNewswire/ -- The three-day Asia photovoltaic event, PV EXPO 2026, concluded today at Tokyo Big Sight. BILIGHT, a global leader in flexible perovskite technology, delivered an impressive performance, securing preliminary...

Ribo to present ex-hepatic delivery data at RNA Leaders Europe Conference

Ribo to present ex-hepatic delivery data at RNA Leaders Europe Conference

SUZHOU, China and MÖLNDALS, Sweden, March 17, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) has been invited to give a speech at the RNA Leaders Europe Conference in Vienna,...

Advantech to Showcase Edge AI and Physical AI Innovations at NVIDIA GTC 2026

Advantech to Showcase Edge AI and Physical AI Innovations at NVIDIA GTC 2026

Featuring robotics, medical AI, and industrial edge deployment powered by NVIDIA Jetson Thor TAIPEI, March 17, 2026 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in IoT intelligent systems and embedded platforms, announced it will...

Shoplazza Adopts Agentic Commerce Architecture to Power AI-Driven E-commerce Operations

Shoplazza Adopts Agentic Commerce Architecture to Power AI-Driven E-commerce Operations

TORONTO, March 17, 2026 /PRNewswire/ -- Shoplazza, a global commerce platform serving direct-to-consumer (DTC) brands, today announced the adoption of an Agentic Commerce architecture across its platform, introducing AI agents that can directly...

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

SUZHOU, China, March 17, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed...

Mitrade Secures Five Global Industry Awards in 2026 as Asia Traders Reassess Counterparty Risk

Mitrade Secures Five Global Industry Awards in 2026 as Asia Traders Reassess Counterparty Risk

KUALA LUMPUR, Malaysia, March 17, 2026 /PRNewswire/ -- CFD broker Mitrade announced five awards, positioning the recognition against a backdrop of heightened volatility and monetary divergence across the region. The US-Iran conflict and Tehran's...

Video series features CPPCC members' insights on China's next development stage

Video series features CPPCC members' insights on China's next development stage

BEIJING, March 17, 2026 /PRNewswire/ -- A special video series produced by the China Daily Opinion Channel during the annual two sessions brings together perspectives from five national political advisers on priorities for the 15th Five-Year Plan...

NPC deputies outline vision for 15th Five-Year Plan

NPC deputies outline vision for 15th Five-Year Plan

BEIJING, March 17, 2026 /PRNewswire/ -- As 2026 marks the start of China's 15th Five-Year Plan (2026-30) period, China Daily Opinion Channel has launched the special program Dialogues with Thinkers during the two sessions, inviting five NPC deputies...

1 ... 470 471 472 473 474 475 476 477 478 ... 4443
menu
menu